Phenotype
|
Fish
|
Conditions
|
Figures
|
optic tectum morphology, abnormal
|
AB + MO1-rpl5a
|
standard conditions
|
Fig. 3
from Uechi et al., 2006
|
whole organism abce1 expression decreased amount, abnormal
|
AB + MO1-rpl5a
|
standard conditions
|
Fig. 3
from Wan et al., 2016
|
hematopoietic stem cell myb expression decreased amount, abnormal
|
AB + MO1-rpl5a
|
standard conditions
|
Fig. 2
from Wan et al., 2016
|
midbrain hindbrain boundary morphology, abnormal
|
AB + MO1-rpl5a
|
standard conditions
|
Fig. 3
from Uechi et al., 2006
|
whole organism mir10a expression increased amount, abnormal
|
AB + MO1-rpl5a
|
standard conditions
|
Fig. 5
from Wan et al., 2016
|
erythroid progenitor cell gata1a expression decreased amount, abnormal
|
AB + MO1-rpl5a
|
standard conditions
|
Fig. 2
from Wan et al., 2016
|
primitive hemopoiesis disrupted, abnormal
|
AB + MO1-rpl5a
|
standard conditions
|
Fig. 2
from Wan et al., 2016
|
hindbrain morphology, abnormal
|
AB + MO1-rpl5a
|
standard conditions
|
Fig. 3
from Uechi et al., 2006
|
whole organism nol6 expression decreased amount, abnormal
|
AB + MO1-rpl5a
|
standard conditions
|
Fig. 3
from Wan et al., 2016
|
whole organism utp4 expression decreased amount, abnormal
|
AB + MO1-rpl5a
|
standard conditions
|
Fig. 3
from Wan et al., 2016
|
whole organism mir737 expression increased amount, abnormal
|
AB + MO1-rpl5a
|
standard conditions
|
Fig. 5
from Wan et al., 2016
|
whole organism mir223 expression increased amount, abnormal
|
AB + MO1-rpl5a
|
standard conditions
|
Fig. 5
from Wan et al., 2016
|
common myeloid progenitor spi1b expression decreased amount, abnormal
|
AB + MO1-rpl5a
|
standard conditions
|
Fig. 2
from Wan et al., 2016
|
embryo development disrupted, abnormal
|
AB + MO1-rpl5a
|
standard conditions
|
Fig. 1
from Wan et al., 2016
|
whole organism dre-mir-722 expression increased amount, abnormal
|
AB + MO1-rpl5a
|
standard conditions
|
Fig. 5
from Wan et al., 2016
|
post-vent region morphology, abnormal
|
AB + MO1-rpl5a
|
standard conditions
|
Fig. 3
from Uechi et al., 2006
|
hematopoietic stem cell runx1 expression decreased amount, abnormal
|
AB + MO1-rpl5a
|
standard conditions
|
Fig. 2
from Wan et al., 2016
|
whole organism mir142a expression increased amount, abnormal
|
AB + MO1-rpl5a
|
standard conditions
|
Fig. 5
from Wan et al., 2016
|
head decreased size, abnormal
|
AB + MO1-rpl5a
|
standard conditions
|
Fig. 1
from Wan et al., 2016
|
nucleate erythrocyte decreased amount, abnormal
|
AB + MO1-rpl5a
|
standard conditions
|
Fig. 1
from Wan et al., 2016
|
whole organism mir155 expression increased amount, abnormal
|
AB + MO1-rpl5a
|
standard conditions
|
Fig. 5
from Wan et al., 2016
|
post-vent region curved ventral, abnormal
|
AB + MO1-rpl5a
|
standard conditions
|
Fig. 1
from Wan et al., 2016
|
whole organism tars1 expression decreased amount, abnormal
|
AB + MO1-rpl5a
|
standard conditions
|
Fig. 3
from Wan et al., 2016
|
heart nucleate erythrocyte decreased amount, abnormal
|
AB + MO1-rpl5a
|
standard conditions
|
Fig. 1
from Wan et al., 2016
|
angioblastic mesenchymal cell tal1 expression decreased amount, abnormal
|
AB + MO1-rpl5a
|
standard conditions
|
Fig. 2
from Wan et al., 2016
|
fourth ventricle morphology, abnormal
|
AB + MO1-rpl5a
|
standard conditions
|
Fig. 3
from Uechi et al., 2006
|
whole organism noc2l expression decreased amount, abnormal
|
AB + MO1-rpl5a
|
standard conditions
|
Fig. 3
from Wan et al., 2016
|
definitive hemopoiesis disrupted, abnormal
|
AB + MO1-rpl5a
|
standard conditions
|
Fig. 2
from Wan et al., 2016
|
hematopoietic stem cell runx1 expression amount, ameliorated
|
AB + MO1-rpl5a + MO4-tp53
|
standard conditions
|
Fig. 2
from Wan et al., 2016
|
hematopoietic stem cell myb expression amount, ameliorated
|
AB + MO1-rpl5a + MO4-tp53
|
standard conditions
|
Fig. 2
from Wan et al., 2016
|
common myeloid progenitor spi1b expression amount, ameliorated
|
AB + MO1-rpl5a + MO4-tp53
|
standard conditions
|
Fig. 2
from Wan et al., 2016
|
erythroid progenitor cell gata1a expression amount, ameliorated
|
AB + MO1-rpl5a + MO4-tp53
|
standard conditions
|
Fig. 2
from Wan et al., 2016
|
angioblastic mesenchymal cell tal1 expression amount, ameliorated
|
AB + MO1-rpl5a + MO4-tp53
|
standard conditions
|
Fig. 2
from Wan et al., 2016
|
heart nucleate erythrocyte amount, ameliorated
|
AB + MO1-rpl5a + MO4-tp53
|
standard conditions
|
Fig. 1
from Wan et al., 2016
|
neurocranium malformed, exacerbated
|
WT + MO1-rpl5a
|
chemical treatment by environment: ethanol
|
Fig. 1
from Berres et al., 2017
|
embryonic cranial skeleton morphogenesis decreased process quality, exacerbated
|
WT + MO1-rpl5a
|
chemical treatment by environment: ethanol
|
Fig. 1
from Berres et al., 2017
|
embryonic neurocranium morphogenesis decreased process quality, exacerbated
|
WT + MO1-rpl5a
|
chemical treatment by environment: ethanol
|
Fig. 1
from Berres et al., 2017
|
head apoptotic process increased occurrence, exacerbated
|
WT + MO1-rpl5a
|
chemical treatment by environment: ethanol
|
Fig. 2
from Berres et al., 2017
|
mandibular arch skeleton malformed, exacerbated
|
WT + MO1-rpl5a
|
chemical treatment by environment: ethanol
|
Fig. 1
from Berres et al., 2017
|
cerebellum aplastic, abnormal
|
AB + MO1-rpl5a + MO1-rpl5b
|
standard conditions
|
Fig. 3
from Uechi et al., 2006
|
extension decreased length, abnormal
|
AB + MO1-rpl5a + MO1-rpl5b
|
standard conditions
|
Fig. 3
from Uechi et al., 2006
|
optic tectum opaque, abnormal
|
AB + MO1-rpl5a + MO1-rpl5b
|
standard conditions
|
Fig. 3
from Uechi et al., 2006
|
ball increased size, abnormal
|
AB + MO1-rpl5a + MO1-rpl5b
|
standard conditions
|
Fig. 3
from Uechi et al., 2006
|
optic tectum increased size, abnormal
|
AB + MO1-rpl5a + MO1-rpl5b
|
standard conditions
|
Fig. 3
from Uechi et al., 2006
|
lens decreased size, abnormal
|
AB + MO1-rpl5a + MO1-rpl5b
|
standard conditions
|
Fig. 3
from Uechi et al., 2006
|
retina decreased size, abnormal
|
AB + MO1-rpl5a + MO1-rpl5b
|
standard conditions
|
Fig. 3
from Uechi et al., 2006
|
fin deformed, abnormal
|
AB + MO1-rpl5a + MO1-rpl5b
|
standard conditions
|
Fig. 3
from Uechi et al., 2006
|
otic placode decreased size, abnormal
|
AB + MO1-rpl5a + MO1-rpl5b
|
standard conditions
|
Fig. 3
from Uechi et al., 2006
|
fourth ventricle opaque, abnormal
|
AB + MO1-rpl5a + MO1-rpl5b
|
standard conditions
|
Fig. 3
from Uechi et al., 2006
|
midbrain hindbrain boundary aplastic, abnormal
|
AB + MO1-rpl5a + MO1-rpl5b
|
standard conditions
|
Fig. 3
from Uechi et al., 2006
|
hindbrain undulate, abnormal
|
AB + MO1-rpl5a + MO1-rpl5b
|
standard conditions
|
Fig. 3
from Uechi et al., 2006
|
apoptotic process increased occurrence, abnormal
|
WT + MO1-rpl11 + MO1-rpl23 + MO1-rpl5a
|
standard conditions
|
Fig. S5
from Chakraborty et al., 2009
|
brain deformed, abnormal
|
WT + MO1-rpl11 + MO1-rpl23 + MO1-rpl5a
|
standard conditions
|
Fig. S5
from Chakraborty et al., 2009
|
brain morphogenesis disrupted, abnormal
|
WT + MO1-rpl11 + MO1-rpl23 + MO1-rpl5a
|
standard conditions
|
Fig. S5
from Chakraborty et al., 2009
|